Robb Gary Charlesinsider trades
In SEC Form 4 filings, Robb Gary Charles is listed as Chief Business Officer of Corcept Therapeutics Inc (CORT). Robb Gary Charles reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 28.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CORTCorcept Therapeutics Inc | Chief Business Officer | 8 | Sep 28 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CORTCorcept Therapeutics Inc | Sep 24 | Sep 28 | G | 17,100 | $0.00 | $0 | 14,056 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 24 | Sep 28 | G | 5,000 | $0.00 | $0 | 20,571 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 24 | Sep 28 | G | 5,000 | $0.00 | $0 | 20,571 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 17 | Sep 18 | M | 17,493 | $8.27 | $144,667 | 31,156 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 17 | Sep 18 | M · derivative | 17,493 | $8.27 | $144,667 | 182,507 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 2 | Sep 3 | F | 91 | $113.38 | $10,318 | 13,663 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 1 | Sep 3 | A | 164 | $113.38 | $18,594 | 13,590 | No | Form 4 |
| CORTCorcept Therapeutics Inc | Sep 1 | Sep 3 | A | 164 | $0.00 | $0 | 13,754 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.